CORTESI, Rita
 Distribuzione geografica
Continente #
NA - Nord America 18.736
AS - Asia 10.517
EU - Europa 7.137
SA - Sud America 1.694
AF - Africa 214
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 38.317
Nazione #
US - Stati Uniti d'America 18.371
SG - Singapore 4.080
CN - Cina 2.515
FI - Finlandia 2.205
BR - Brasile 1.333
IT - Italia 1.175
VN - Vietnam 1.104
UA - Ucraina 978
HK - Hong Kong 859
DE - Germania 722
GB - Regno Unito 614
TR - Turchia 526
FR - Francia 341
IN - India 311
JP - Giappone 311
SE - Svezia 277
RU - Federazione Russa 248
PL - Polonia 171
MX - Messico 163
CA - Canada 146
ID - Indonesia 135
AR - Argentina 124
BD - Bangladesh 122
IQ - Iraq 107
ZA - Sudafrica 78
NL - Olanda 77
CO - Colombia 64
PK - Pakistan 60
AT - Austria 59
EC - Ecuador 56
ES - Italia 46
TH - Thailandia 41
LT - Lituania 38
PH - Filippine 36
BE - Belgio 35
KR - Corea 35
VE - Venezuela 32
CL - Cile 31
SA - Arabia Saudita 31
RO - Romania 26
MY - Malesia 25
IL - Israele 24
NP - Nepal 23
UZ - Uzbekistan 23
JO - Giordania 21
IR - Iran 20
MA - Marocco 20
DZ - Algeria 19
EG - Egitto 18
PY - Paraguay 18
AE - Emirati Arabi Uniti 17
CH - Svizzera 17
KE - Kenya 16
CZ - Repubblica Ceca 15
PE - Perù 14
TN - Tunisia 14
PT - Portogallo 13
ET - Etiopia 12
KW - Kuwait 12
UY - Uruguay 12
AL - Albania 11
AZ - Azerbaigian 11
KZ - Kazakistan 11
CR - Costa Rica 10
IE - Irlanda 10
AU - Australia 9
BO - Bolivia 9
DK - Danimarca 9
JM - Giamaica 9
LV - Lettonia 9
NG - Nigeria 9
TW - Taiwan 9
DO - Repubblica Dominicana 8
BF - Burkina Faso 7
GR - Grecia 7
OM - Oman 7
HN - Honduras 6
KG - Kirghizistan 6
MD - Moldavia 6
AO - Angola 5
BG - Bulgaria 5
HU - Ungheria 5
PA - Panama 5
PS - Palestinian Territory 5
SN - Senegal 5
AM - Armenia 4
BH - Bahrain 4
CI - Costa d'Avorio 4
GT - Guatemala 4
HR - Croazia 4
LK - Sri Lanka 4
BB - Barbados 3
BY - Bielorussia 3
LB - Libano 3
MK - Macedonia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
TJ - Tagikistan 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 38.280
Città #
Singapore 2.497
Ashburn 2.208
Helsinki 1.968
Woodbridge 1.701
Fairfield 1.646
Houston 1.262
Jacksonville 1.068
San Jose 963
Santa Clara 915
Chandler 897
Hong Kong 829
Beijing 800
Ann Arbor 691
Seattle 659
Wilmington 607
Cambridge 574
Ho Chi Minh City 399
Izmir 343
Ferrara 323
Nanjing 287
Tokyo 287
Los Angeles 265
Princeton 248
Hanoi 246
Dallas 237
New York 224
Lauterbourg 207
Boardman 183
Council Bluffs 172
Warsaw 153
São Paulo 133
San Diego 130
Munich 116
Mexico City 106
Shanghai 104
Shenyang 89
Milan 86
Nanchang 84
Jakarta 76
Hefei 72
London 72
Dearborn 70
Montreal 65
Chicago 64
Orem 61
Brooklyn 60
Buffalo 60
Jiaxing 60
Chennai 59
Hebei 58
Changsha 56
Bologna 53
Da Nang 52
Redwood City 51
Frankfurt am Main 50
Tianjin 49
Moscow 46
Rio de Janeiro 46
Baghdad 44
Boston 44
Haiphong 44
Vienna 42
Johannesburg 41
Denver 39
Atlanta 38
San Francisco 38
Stockholm 38
Manchester 37
The Dalles 36
Turku 36
Falkenstein 35
Poplar 34
Belo Horizonte 33
Brussels 33
Jinan 33
Mumbai 32
Norwalk 32
San Mateo 32
Mountain View 31
Rome 30
Toronto 30
Ningbo 29
Falls Church 28
Addison 27
Amsterdam 26
Ankara 26
Guangzhou 26
New Delhi 24
Zhengzhou 23
Indiana 22
Orange 22
Kunming 21
Tashkent 21
Auburn Hills 20
Biên Hòa 20
Curitiba 20
Ferrara di Monte Baldo 20
Lahore 20
Verona 20
Amman 19
Totale 26.153
Nome #
Microemulsions of retinoids and pharmaceutical compositions containing them 1.968
Structural studies of lipid based nanosystems for drug delivery: X-Ray Diffraction (XRD) and Cryogenic Transmission Electron Microscopy (cryo-TEM) 404
Biodistribution of nanostructured lipid carriers: a tomographic study 326
Effect of new Curcumin-containing nanostructured lipid dispersions on human keratinocytes proliferative responses 285
Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo study 265
Aminated polysaccharide microspheres as DNA delivery systems 252
Nafion®-containing solid lipid nanoparticles as a tool for anticancer pt delivery: preliminary studies 244
Skin care: The innovative nanotechnology to improve the performance of delivery systems 242
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 239
Acyclovir delivery systems 233
Cationic lipospheres as delivery systems for nucleic acid molecules 232
Nuove strategie per la veicolazione di acidi nucleici: nanosistemi cationici a matrice lipidica 230
Analysis of the drug release profiles from formulations based on micro and nano systems 228
Cationic lipid nanosystems as carriers for nucleic acids 228
Nanostructured lipid carriers (NLC) for the delivery of natural molecules with antimicrobial activity: production, characterisation and in vitro studies 226
Amphiphilic association systems for amphotericin B delivery 225
Biodegradable microparticles for sustained delivery of tetracycline to the periodontal pocket: Formulatory and drug release studies 217
Clotrimazole Nanoparticle gel for mucosal administration. 217
Design and characterization of ethosomes for transdermal delivery of caffeic acid 217
Cellulose acetate butyrate-pH/thermosensitive polymer microcapsules containing aminated poly(vinyl alcohol) microspheres for oral administration of DNA 215
Cubosome dispersions as delivery systems for percutaneous administration of indomethacin 214
Lipid-based nanoparticles containing cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as innovative vehicle for Pt complexes: production, characterization and in vitro studies 214
Design of Nanosystems for the Delivery of Quorum Sensing Inhibitors: A Preliminary Study 212
Amphiphilic association systems for Amphotericin B delivery 211
A novel multicompartimental system based on aminated poly(vinyl alcohol) microspheres/succinoylated pullulan microspheres for oral delivery of anionic drugs 208
Ursodeoxycholic acid for oral administration: a formulatory study of a suspension. 207
Monoolein Aqueous Dispersions as a delivery system for quercetin 205
Data on scaling up and in vivo human study of progesterone lipid nanoparticles 204
L-dopa co-drugs in nanostructured lipid carriers: a comparative study 201
Antisense oligonucleotides conjugated with lipophilic compounds: synthesis and in vitro evaluation of exon skipping in duchenne muscular dystrophy 201
Formulations for natural and peptide nucleic acids based on cationic polymeric submicron particles 200
Progesterone lipid nanoparticles: Scaling up and in vivo human study 200
Budesonide microparticles for the treatment of Crohn's disease 199
Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study 199
Nanoformulations for dimethyl fumarate: Physicochemical characterization and in vitro/in vivo behavior 199
Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity 199
Non-phospholipid vesicles as carriers for peptides and proteins: production, characterization and stability studies 198
Formulation study for the antitumor drug camptothecin: liposomes, micellar solutions and a microemulsion 198
Ethosomes and organogels for cutaneous administration of crocin 198
Encapsulation of cannabinoid drugs in nanostructured lipid carriers 198
Design and characterization of fenretinide containing organogels 195
Production of lipospheres as carriers for bioactive compounds 194
Nanostructured lipid systems modified with waste material of propolis for wound healing: design, in vitro and in vivo evaluation 194
Cationic lipid nanosystems as carriers for nucleic acids 194
Liposomes as carriers for DNA-PNA hybrids 193
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 193
Gallic acid loaded poloxamer gel as new adjuvant strategy for melanoma: A preliminary study 193
Lipid nanocarriers containing a Levodopa prodrug with potential antiparkinsonian activity 193
A correlative imaging study of in vivo and ex vivo biodistribution of solid lipid nanoparticles 192
Gelified reverse micellar dispersions as percutaneous formulations 191
Investigation of the bioequivalence of Rosuvastatin 20 mg tablets after a single oral administration in mediterranean arabs using a validated LC MS/MS method 191
"Plurethosome" as vesicular system for cutaneous administration of mangiferin: formulative study and 3D skin tissue evaluation 191
Microparticles containing gallic and ellagic acids for the biological control of bacterial diseases of kiwifruit plants 190
Active substance controlled release device for sanitization of spaces susceptible of containing degenerative organic material 189
Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (ii) carboxylates 189
Effects of phospholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate 186
Nanostructured lipid dispersions for topical administration of crocin, a potent antioxidant from saffron (Crocus sativus L.) 185
Influence of formulation and process parameters on pellet production by powder layering technique 184
Microparticles as delivery systems for local delivery to the oral cavity. 183
Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin 183
Challenges in the physical characterization of lipid nanoparticles 183
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 182
Clotrimazole-loaded nanostructured lipid carrier hydrogels: thermal analysis and in vitro studies 181
Kinetics of bromocriptine release from microspheres: Comparative analysis between different in vitro models 180
Cellulose acetate butyrate microcapsules containing dextran ion-exchange resins as self-propelled drug release system 180
Nanosistemi lipidici per la veicolazione di acidi nucleici 179
Polymeric microparticles for fenretinide administration 179
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 178
Eudragit® microparticles for the release of budesonide: A comparative study 177
Preparation of liposomes by reverse-phase evaporation using alternative organic solvents 176
Ethosomes and liposomes as topical vehicles for azelaic acid: A preformulation study 175
Nanosystems for skin hydration: a comparative study 174
Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA 174
Liposome-associated retinoids: production, characterization and antiproliferative activity on neoplastic cells 173
Curcumin containing monoolein aqueous dispersions: a preformulative study 173
In vitro effect on human leukemic K562 cells of co-administration of liposome-associated retinoids and cytosine arabinoside (Ara-C) 172
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 171
In vitro cytotoxic activity of some glucosinolate-derived products generated by myrosinase hydrolysis 170
Lipid-based supramolecular systems for topical application: A preformulatory study 170
Lipid nanoparticles for administration of poorly water soluble neuroactive drugs 170
Preparation of high-solid PLA waterborne dispersions with PEG-PLA-PEG block copolymer as surfactant and their use as hydrophobic coating on paper 169
Cationic nanostructured lipid carrier (NLC) and monoolein aqueous dispersions (MAD) as potential carriers for nucleic acids 169
Long-chain cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as new components of potential non-viral vectors 169
Pharmaceutical and biotechnological applications of multiple emulsions 168
Gelatin microspheres: Influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties 168
Preparation and characterisation of thermoresponsive poly [(N-isopropylacrylamide-co-acrylamide-co(hydroxyethyl acrylate)] microspheres as a matrix for the pulsed release of drugs 168
Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles 166
Ethosomes and transethosomes for mangiferin transdermal delivery 165
GELATIN MICROSPHERES AS A NEW APPROACH FOR THE CONTROLLED DELIVERY OF SYNTHETIC OLIGONUCLEOTIDES AND PCR-GENERATED DNA FRAGMENTS 164
Human leukemic K562 cells treated with cytosine arabinoside: enhancement of erythroid differentiation by retinoic acid and retinol 163
Eudragit® /Pluronic nanoparticles as mucosal delivery system for peptides and proteins: an in vitro study 163
Cationic phosphines for the obtaining of non-viral vectors 163
The potential of caffeic acid lipid nanoparticulate systems for skin application: in vitro assays to assess delivery and antioxidant effect 163
Properties and applications of liposomes in cosmetics 162
Effect of DNA complexation and freeze-drying on the physicochemical characteristics of cationic liposomes 162
Sugar cross-linked gelatin for controlled release: microspheres and disks 162
Influence of liposomal formulation parameters on the in vitro absorption of methyl nicotinate 162
Cubic Phases, Cubosomes and Ethosomes for Cutaneous Application 162
Production, physico-chemical characterization and biodistribution studies of lipid nanoparticles 161
Production of lipospheres for bioactive compounds delivery 159
Totale 21.366
Categoria #
all - tutte 162.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 8.017
Totale 170.871


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.034 0 0 0 0 0 0 0 0 0 471 362 201
2021/20222.239 106 276 172 123 63 110 122 148 74 208 210 627
2022/20232.222 257 75 69 256 369 376 72 212 293 18 149 76
2023/20241.229 147 150 58 35 91 247 68 67 20 38 54 254
2024/20255.244 157 122 422 163 708 531 131 389 906 482 784 449
2025/202615.204 1.320 692 1.255 1.871 1.876 879 1.632 910 3.232 1.537 0 0
Totale 38.718